A simple Lung Cancer Screen blood test designed to help assess lung cancer risk earlier
The EarlyCDT® Lung Cancer Blood Test is a clinically developed blood test that detects specific autoantibodies associated with lung cancer. These autoantibodies can appear in the blood months or even years before symptoms develop, offering the opportunity for earlier clinical assessment.
This test is intended for individuals who may be at increased risk of lung cancer, including current or former smokers, or those with a relevant personal or occupational exposure history.
Cancer cells can trigger the immune system to produce autoantibodies at very early stages of disease development. The EarlyCDT® Lung test looks for a specific panel of these autoantibodies using a single blood sample.
Simple blood test – requires only a standard blood draw
Early risk insight – may detect immune responses associated with lung cancer before symptoms appear
Clinically validated technology – backed by peer-reviewed research
Non-invasive – no scans or imaging required at the testing stage
Supports clinical decision-making – results can be shared with your healthcare professional
Current or former smokers
Individuals aged 40+ with increased lung cancer risk factors
Those seeking additional information to support discussions with their clinician
Couldn't load pickup availability
Enquire via the form and a member of our team will get back to you, they are more than happy to help answer your questions and talk through the best option for you.
Contact us if you aren't sure, we'd be happy to help!
PLACING AN ORDER
ARRANGING AN APPOINTMENT
AFTER YOUR TEST
When you’re worried about your health, life can feel very stressful, especially if you don’t have the answers you need. We believe that health testing should be available to all, giving you answers when and where you need them.
That’s why we’ve partnered with Splitit, Dopple and Clearpay so you can pay for your tests in interest-free instalments, if you prefer.